Fundraising FoxKendall Capital Partners — Full Portfolio
14 tracked investments · listed companies and verified rows first
Biotechnology company using multiplex gene editing to develop genetically engineered porcine organs for human transplantation.
BiotechBrookline, US
Luhan Yang(President, Secretary and Treasurer)Geoff MacKay(Chief Executive Officer)
Board seatGeorge M. Church· per SEC Form D · $3M raise · filed Aug 2016
Co-investorsAlta PartnersARCH Venture PartnersCatalio Capital Management, LPHBM Healthcare InvestmentsHBM PartnersKhosla Ventures+12 more
EpiBone engineers bone tissue from stem cells for regenerative medicine and clinical reconstruction, serving patients requiring bone grafts or craniofacial repair.
BiotechHealthtechMedical DevicesNew York, US
Nina Tandon(Co-Founder, CEO)inSarindr Bhumiratana(Co-Founder)inGordana Vunjak-Novakovic(Director)Elma Hawkins(Director)
BoardDavid Zhu(Director)in
Board seatRobert Langer· per SEC Form D
Co-investorsBeresford VenturesCatalytic Impact FoundationEMV CapitalHackensack Meridian Health Bear's DenLifespan Vision VenturesMEDA Angels+3 more
BiotechCambridge, US
Torben Straight Nissen(Executive Officer, Director)inJoanne Protano(Executive Officer)inDavid Epstein(Director)Harvey F. Lodish(Director)Michael Rosenblatt(Director)Roger Pomerantz(Director)in
Board seatRobert Langer· per SEC Form D · $120M raise · filed Jun 2017
Co-investorsFlagship PioneeringFlagship Ventures
BiotechWatertown, US
Omid Farokhzad(Director)inRobert S. Langer, Jr.(Director)Robert S. Langer(Director)Andrew J. Fromkin(Executive Officer, Director)Leila Alland(Executive Officer)inRichard Wooster(Executive Officer)in
Board seatRobert Langer· per SEC Form D · $38M raise · filed Feb 2017
Co-investors+ND CapitalNew Enterprise Associates (NEA)
Blu Wireless develops millimeter wave radio networking technology for wireless communications.
Deep TechDefense TechHardwareSemiconductorsBristol, GB
Anthony Murray(Chief Executive Officer)inJohnny Bray(Chief Financial Officer)inDave Purle(Chief Operating Officer)Ciara Barron(Director of Marketing)inDarren McNamara(Director of Technology Development)inJonathan Rogers(Director of Systems and Platforms)in
Co-investorsMaven Capital PartnersCambridge Angels groupPerscitus LLPSalica InvestmentsARMCalculus Capital Ltd.+1 more
Centivax is a biotechnology company developing broad-spectrum vaccines, including a universal influenza vaccine.
BiotechHealthtech
Jacob Glanville(Founder)inStephanie Wisner(Founder)in
Co-investorsAmplify PartnersBold Capital PartnersFuture VenturesGlobal Health Investment CorporationNFX
Eyenuk provides autonomous AI-based eye exams performed at the point of care to detect eye conditions including diabetic retinopathy (DR), age-related macular degeneration (AMD), and glaucomatous signs.
AI & Machine LearningDigital HealthHealthtechMedical DevicesWoodland Hills, US
Kaushal Solanki(Founder; Director, PhD)inGaurav Agarwal(Chief Executive Officer)in
BoardMads Dall(Director)Zina Affas Besse(Director)Marie-Louise Little(Director)
General Fluidics builds Axess, a point-of-care diagnostic analyzer powered by its patented Embedded Fluidics Systems that runs clinical chemistry, hematology, and immunoassay panels from a single cartridge in under 20 minutes.
HardwareHealthtechMedical DevicesWaltham, US
Robert Granier(Executive Officer, Director)inRobert Warren(Executive Officer)inJason Napolitano(Director)Ronald Tompkins(Director)
BoardMarc Goldberg(Director)Timothy Hirsch(Director)
Rejuvenate Bio develops gene therapy treatments aimed at the root causes of aging to address chronic, age-related conditions such as osteoarthritis, heart disease, and cancer.
BiotechHealthtechLongevitySan Diego, US
Noah Davidsohn(CSO, Co-Founder)inDaniel Oliver(CEO, Co-Founder)inGeorge Church(Co-Founder and SAB)Deborah Ascheim(Chief Medical Officer)in
BoardDavid Zhu(Director)in
Co-investorsCompanion FundConnecticut InnovationsDigitalis VenturesGaingelsLifespan Vision VenturesVCapital+1 more
__Twitter.png)
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Bilayer TherapeuticsFrequency TherapeuticsLyndraMicrochips BiotechOmniPulse Biosciences
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.